What is the PANAS (Positive and Negative Affect Schedule) questionnaire and how is it administered in clinical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PANAS Questionnaire Overview

The PANAS (Positive and Negative Affect Schedule) is a validated 20-item self-report questionnaire that measures two independent dimensions of affect: Positive Affect (PA) and Negative Affect (NA), with each subscale containing 10 items rated on a Likert scale. 1

Structure and Administration

The PANAS consists of:

  • 10 Positive Affect items: measuring emotions like cheerful, enthusiastic, energetic, content
  • 10 Negative Affect items: measuring emotions like anxious, guilty, insecure, lonely, suspicious

Scoring uses a 7-point Likert scale where respondents rate the extent to which they have experienced each emotion 2. The instrument can assess:

  • State affect: "How do you feel right now, at this moment?"
  • Trait affect: "How do you generally feel?"

Psychometric Properties

The PANAS demonstrates robust validity across diverse populations:

  • Internal consistency: Cronbach's alpha and McDonald's omega both exceed 0.80 for both PA and NA subscales 2, 3
  • Factor structure: Confirmatory factor analysis consistently supports a two-factor model (PA and NA as independent dimensions) across multiple cultural adaptations 2, 3, 4, 5
  • Temporal stability: Test-retest reliability over 2 months shows appropriate stability (ICC = 0.806-0.831) 1, 5

Clinical Validity

The PANAS shows strong convergent validity with established clinical measures:

  • PA correlates negatively with: Depression severity (HDRS-6: r = -.37), anxiety (HARS-6: r = -.15), and personality detachment (r = -.47) 2
  • NA correlates positively with: Depression (HDRS-6: r = .52), anxiety (HARS-6: r = .51), and negative affectivity traits (r = .43) 2

The instrument has been validated in clinical populations with emotional disorders including depression, anxiety disorders, and adjustment disorders 3, demonstrating sensitivity to change following treatment interventions 3.

Clinical Context

While the PANAS is not specifically listed in ASCO guidelines for depression and anxiety screening [6-6], it serves as a complementary assessment tool. The guidelines prioritize PHQ-9 for initial depression screening, with other measures like Beck Depression Inventory, GAD-7, and HADS as alternatives 6.

The PANAS offers distinct advantages:

  • Measures affective dimensions rather than diagnostic criteria
  • Brief administration time (typically 5-10 minutes)
  • Available in validated online formats 3
  • Cross-culturally validated in multiple languages 2, 3, 4, 5

Practical Application

Administer the PANAS by having patients rate 20 emotion words on a 7-point scale (1 = very slightly or not at all, to 7 = extremely). Calculate separate scores for PA (sum of 10 positive items) and NA (sum of 10 negative items). The two dimensions are largely independent, meaning patients can score high or low on both simultaneously 1.

Short forms exist (typically 10 items total, 5 per dimension) with comparable psychometric properties, useful when assessment time is limited 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.